Characteristics of drug-related problems among hospitalized ischemic stroke patients in China
- PDF / 582,814 Bytes
- 5 Pages / 595.276 x 790.866 pts Page_size
- 2 Downloads / 173 Views
SHORT RESEARCH REPORT
Characteristics of drug‑related problems among hospitalized ischemic stroke patients in China Qingqing Chen1 · Zhao Jin1 · Ping Zhang1 · Shusen Sun2,3,4 · Ling Li1 · Yun Liao1 Received: 13 November 2019 / Accepted: 6 June 2020 © Springer Nature Switzerland AG 2020
Abstract Background Patients with ischemic stroke are often taking multiple medications and are at increased risk for drug-related problems (DRPs). However, the prevalence and nature of DRPs in these patients in China and the impact of pharmacist interventions to resolve DRPs in this population are unknown. Objective To investigate the prevalence and nature of DRPs in ischemic stroke patients. Setting A neurology ward at an academic teaching hospital in Shanghai, China. Methods This was a prospective observational study conducted from September to November 2017. A total of 274 ischemic stroke adult patients were included. Pharmacists provided pharmaceutical care activities in the multi-disciplinary team. DRPs were categorized by the Pharmaceutical Care Network Europe classification V8.0. Main outcome measure The number, types, and causes of DRPs. Results We identified 88 DRPs related to 89 causes, an average rate of 0.32 DRP per patient. The rates of DRPs were higher in patients with renal impairment (0.91), liver impairment (0.65), or patients younger than 60 years (0.39). The primary cause of the DRPs was drug selection (66.3%), and the most common problem was treatment safety (60.2%). Among the top medications associated with DRPs were proton pump inhibitors (17.2%) followed by cerebrovascular/nootropics (16.1%) and sedative-hypnotics (13.9%). The acceptance rate of pharmacists’ inventions reached 94.0%, and 90.0% of these accepted inventions were fully implemented (DRP status solved). Conclusion Drug-related problems are relatively common in hospitalized ischemic stroke patients in China, and treatment safety is the major DRP type. Pharmacist intervention can identify and resolve pertinent DRPs to optimize medication therapy. Keywords China · Drug-related problems · Ischemic stroke · PCNE classification · Pharmacists
Impacts on practice • Drug-related problems (DRPs) are relatively common in
hospitalized ischemic stroke patients in China.
* Yun Liao [email protected] 1
Department of Pharmacy, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, 1111 Xianxia Road, Shanghai 200336, People’s Republic of China
Department of Pharmacy Practice, College of Pharmacy and Health Sciences, Western New England University, 1215 Wilbraham Road, Springfield, MA 01119, USA
2
3
Department of Pharmacy, Xiangya Hospital Central South University, Changsha 410008, Hunan Province, People’s Republic of China
4
Institute for Rational and Safe Medication Practices, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, Hunan, People’s Republic of China
• Treatment safety is the major type of DRP in hospitalized
ischemic stroke patients in China
Data Loading...
